National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

octreotide pamoate
A synthetic long-acting octapeptide analogue of endogenous somatostatin. Octreotide pamoate binds to somatostatin receptors expressed by some neuroendocrine and non-neuroendocrine tumor cells, thereby initiating somatostatin receptor-mediated apoptosis. Other possible antineoplastic activities of this agent include suppression of tumor angiogenesis and tumor growth-promoting insulin-like growth factor 1 (IGF-1). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:octreotide pamoate LAR(SMS 201-995)
OP LAR
US brand names:OncoLAR
Sandostatin pamoate
Sandostatin pamoate LAR
Code names:SMS 201-995 pa
SMS 201-995 pa LAR



Previous:NY-ESO-B, O6-benzylguanine, obatoclax mesylate, oblimersen, octreotide acetate
Next:Oestrogenine, Oestromenin, Oestromon, ofatumumab, ofloxacin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov